Position in RPRX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,073,420
+$895,870 QoQ
Shares Held
54,814
+20.8% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#240
of 641 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KEYBANK NATIONAL ASSOCIATION/OH holds $23,001,658 across 27 Biotechnology names. RPRX ranks #2 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,934 | $4,934,515 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
54,814 | $3,073,420 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
10,084 | $2,429,940 | |
| 4 | ARGX |
Argenx SE
|
1,718 | $1,593,908 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,132 | $1,329,386 | |
| 6 | GMAB |
Genmab A/S
|
31,068 | $853,437 | |
| 7 | INSM |
INSMED Inc
|
7,252 | $773,207 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
2,049 | $647,668 |
All Filings in RPRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,073,420 | 54,814 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $2,177,550 | 45,394 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $1,496,371 | 38,726 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $1,242,279 | 35,212 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $1,193,997 | 33,139 | Shares | Defined | 2025-08-04 | |
| 2025-03-31 | $1,021,624 | 32,818 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $718,157 | 28,152 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $810,423 | 28,647 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $620,565 | 23,533 | Shares | Defined | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||